Nuñez, Finn Abrielle Jace N.

HRN: 28-92-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
AMPICILLIN 250MG (VIAL)
05/03/2026
05/10/2026
IV
165mg
Q12hours
Omphalitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: